These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 14447657)

  • 1. Cutaneous lesion of progressive systemic sclerosis.
    JAMA; 1961 Apr; 175():1175. PubMed ID: 14447657
    [No Abstract]   [Full Text] [Related]  

  • 2. Pathologic observations concerning the cutaneous lesion of progressive systemic sclerosis: an electron microscopic histochemical and immunohistochemical study.
    FISHER ER; RODNAN GP
    Arthritis Rheum; 1960 Dec; 3():536-45. PubMed ID: 13699954
    [No Abstract]   [Full Text] [Related]  

  • 3. Distinct gene network in skin lesion of patients with diffuse cutaneous systemic sclerosis.
    Inamo J
    Clin Rheumatol; 2020 Oct; 39(10):3143-3144. PubMed ID: 32588276
    [No Abstract]   [Full Text] [Related]  

  • 4. Lenabasum for Skin Disease in Patients With Diffuse Cutaneous Systemic Sclerosis.
    Hinchcliff M
    Arthritis Rheumatol; 2020 Aug; 72(8):1237-1240. PubMed ID: 32368869
    [No Abstract]   [Full Text] [Related]  

  • 5. The cutaneous collagenoses.
    Reed RJ; Clark WH; Mihm MC
    Hum Pathol; 1973 Jun; 4(2):165-86. PubMed ID: 4574685
    [No Abstract]   [Full Text] [Related]  

  • 6. The nature of joint involvement in progressive systemic sclerosis (diffuse scleroderma).
    RODNAN GP
    Ann Intern Med; 1962 Mar; 56():422-39. PubMed ID: 14493143
    [No Abstract]   [Full Text] [Related]  

  • 7. PANAORTITIS AND AORTIC VALVULITIS IN PROGRESSIVE SYSTEMIC SCLEROSIS (SCLERODERMA).
    ROTH LM; KISSANE JM
    Am J Clin Pathol; 1964 Mar; 41():287-96. PubMed ID: 14131864
    [No Abstract]   [Full Text] [Related]  

  • 8. Generalized morphea-like systemic sclerosis : a subtype of diffuse cutaneous systemic sclerosis presenting with unusual cutaneous features.
    Nagai Y; Igarashi N; Ishikawa O
    Eur J Dermatol; 2008; 18(6):715-6. PubMed ID: 19049937
    [No Abstract]   [Full Text] [Related]  

  • 9. Progressive systemic sclerosis sine scleroderma.
    RODNAN GP; FENNELL RH
    JAMA; 1962 May; 180():665-70. PubMed ID: 14493142
    [No Abstract]   [Full Text] [Related]  

  • 10. [Progressive systemic sclerosis-scleroderma. Experience with 67 cases].
    GONZALEZ A
    Rev Med Chil; 1959 Jul; 87():498-516. PubMed ID: 13850974
    [No Abstract]   [Full Text] [Related]  

  • 11. [On the morphology of the autonomic nervous system of the human skin with studies on neuropathological changes in various skin diseases. Neurohistological studies on lichen sclerosus et atrophicus, superficial, small-spotted scleroderma and diffuse scleroderma with comparative pathogenetic considerations. Part IV].
    THIES W
    Z Haut Geschlechtskr; 1960 Jan; 28():37-59. PubMed ID: 13837846
    [No Abstract]   [Full Text] [Related]  

  • 12. Fixation of S 35 in the skin of patients with progressive systemic sclerosis.
    DENKO CW; STOUGHTON RB
    Arthritis Rheum; 1958 Feb; 1(1):77-81. PubMed ID: 13510133
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal involvement in progressive systemic sclerosis (scleroderma).
    LEVINE RJ; BOSHELL BR
    Ann Intern Med; 1960 Mar; 52():517-29. PubMed ID: 14416278
    [No Abstract]   [Full Text] [Related]  

  • 14. Comment on: Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis.
    Bosello S; Gremese E; Ferraccioli G
    Rheumatology (Oxford); 2020 Jul; 59(7):1782-1783. PubMed ID: 32160296
    [No Abstract]   [Full Text] [Related]  

  • 15. RISE-SSc: Riociguat in diffuse cutaneous systemic sclerosis.
    Distler O; Pope J; Denton C; Allanore Y; Matucci-Cerinic M; de Oliveira Pena J; Khanna D
    Respir Med; 2017 Jan; 122 Suppl 1():S14-S17. PubMed ID: 27746061
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comment on: Skin improvement is a surrogate for favourable changes in other organ systems in early diffuse cutaneous systemic sclerosis: reply.
    Nevskaya T; Zheng B; Baxter C; Ramey D; Pope JE; Baron M
    Rheumatology (Oxford); 2020 Jul; 59(7):1783-1784. PubMed ID: 32160293
    [No Abstract]   [Full Text] [Related]  

  • 17. [Dermatologic and visceral aspects of diffuse and progressive scleroderma (acro-sclerosis) (3 cases)].
    BECHELLI LM; FONSECA LC; PIMENTA WP
    An Bras Derm Sifilogr; 1956 Mar; 31(1):17-45. PubMed ID: 13362913
    [No Abstract]   [Full Text] [Related]  

  • 18. The heart in generalized scleroderma; progressive systemic sclerosis.
    GOETZ RH
    Angiology; 1951 Dec; 2(6):555-78. PubMed ID: 14894860
    [No Abstract]   [Full Text] [Related]  

  • 19. Cutaneous Manifestations of Scleroderma and Scleroderma-Like Disorders: a Comprehensive Review.
    Ferreli C; Gasparini G; Parodi A; Cozzani E; Rongioletti F; Atzori L
    Clin Rev Allergy Immunol; 2017 Dec; 53(3):306-336. PubMed ID: 28712039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Renal involvement in progressive systemic sclerosis (generalized scleroderma).
    RODNAN GP; SCHREINER GE; BLACK RL
    Am J Med; 1957 Sep; 23(3):445-62. PubMed ID: 13458209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.